financetom
Business
financetom
/
Business
/
VNET Q3 Swings to Profit, Revenue Rises; Ups Revenue Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
VNET Q3 Swings to Profit, Revenue Rises; Ups Revenue Guidance
Nov 20, 2024 7:32 PM

05:20 PM EST, 11/20/2024 (MT Newswires) -- VNET Group ( VNET ) reported Q3 earnings late Wednesday of 0.30 Chinese renminbi ($0.06) per diluted American depositary share, compared with a loss of 0.36 renminbi a year earlier.

Analysts polled by Factset expected 0.23 renminbi.

Revenue for the quarter ended Sept. 30 rose to 2.12 billion renminbi from 1.89 billion renminbi a year earlier.

Analysts surveyed by Factset expected 2.02 billion renminbi.

The company said it increased its 2024 net revenue projections to between 8 billion renminbi to 8.1 billion renminbi from previous estimate of 7.80 billion renminbi to 8 billion renminbi. The consensus is for 7.99 billion renminbi.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pumping solutions provider DXP's Q3 sales beat estimates
Pumping solutions provider DXP's Q3 sales beat estimates
Nov 6, 2025
Overview * DXP Q3 sales grow 8.6% yr/yr, beating analyst expectations * Net income for Q3 misses analyst estimates * Company completed three acquisitions in Q3, two more after quarter end Outlook * Company expects to finish fiscal year 2025 strong with momentum into fiscal year 2026 Result Drivers * ACQUISITIONS - Co completed three acquisitions in Q3 and two...
Sangamo Therapeutics Q3 revenue falls short, net loss widens
Sangamo Therapeutics Q3 revenue falls short, net loss widens
Nov 6, 2025
Overview * Sangamo Q3 2025 revenue misses analyst expectations, declining significantly from last year * Net loss for Q3 2025 was $34.9 mln, compared to net income last year * Company progresses Fabry disease program, preparing for BLA submission in 2026 Outlook * Sangamo expects BLA submission for Fabry disease in Q1 2026 * Company plans CTA submission for prion...
Viagra-maker Viatris beats quarterly estimates on strong demand for branded drugs
Viagra-maker Viatris beats quarterly estimates on strong demand for branded drugs
Nov 6, 2025
Nov 6 (Reuters) - Drugmaker Viatris beat third-quarter estimates for profit and revenue on Thursday, driven by strong demand for its branded drugs in China and emerging markets. The company also raised its 2025 forecasts, which financial chief Doretta Mistras said was primarily based on foreign exchange benefits and share repurchases. In August, the drugmaker had said that it expects...
Granite Construction Q3 Adjusted Earnings, Revenue Rise; 2025 Revenue Guidance Narrowed
Granite Construction Q3 Adjusted Earnings, Revenue Rise; 2025 Revenue Guidance Narrowed
Nov 6, 2025
08:12 AM EST, 11/06/2025 (MT Newswires) -- Granite Construction ( GVA ) reported Q3 adjusted earnings Thursday of $2.70 per diluted share, up from $2.05 a year earlier. Three analysts polled by FactSet expected $2.38. Revenue for the quarter ended Sept. 30 was $1.43 billion, compared with $1.28 billion a year earlier. Three analysts surveyed by FactSet expected $1.48 billion....
Copyright 2023-2026 - www.financetom.com All Rights Reserved